Titan Pharmaceuticals and CVS Health's CVS Caremark have entered a deal to distribute Titan's Probuphine subdermal implant, a buprenorphine-delivery implant designed for patients with opioid use disorder. Titan expects the specialty pharmacy distribution system to account for most of the implant's sales in the US.
Titan, CVS sign distribution deal for Probuphine implant
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.